Haixia He - Search Results

Year	Number of Results
1999	1
2008	2
2009	2
2010	4
2011	1
2012	2
2013	4
2014	1
2015	1
2016	2
2017	3
2018	5
2019	1
2020	6
2021	10
2022	4
2023	8
2024	2

1

Assessment of treatment outcomes: cytoreductive surgery compared to radiotherapy in oligometastatic prostate cancer - an in-depth quantitative evaluation and retrospective cohort analysis.

Cheng B, He H, Chen B, Zhou Q, Luo T, Li K, Du T, Huang H. Cheng B, et al. Among authors: he h. Int J Surg. 2024 Mar 18. doi: 10.1097/JS9.0000000000001308. Online ahead of print. Int J Surg. 2024. PMID: 38498388

2

EpCAM-targeting CAR-T cell immunotherapy is safe and efficacious for epithelial tumors.

Li D, Guo X, Yang K, Yang Y, Zhou W, Huang Y, Liang X, Su J, Jiang L, Li J, Fu M, He H, Yang J, Shi H, Yang H, Tong A, Chen N, Hu J, Xu Q, Wei YQ, Wang W. Li D, et al. Among authors: he h. Sci Adv. 2023 Dec;9(48):eadg9721. doi: 10.1126/sciadv.adg9721. Epub 2023 Dec 1. Sci Adv. 2023. PMID: 38039357 Free PMC article.

3

MT1G, an emerging ferroptosis-related gene: A novel prognostic biomarker and indicator of immunotherapy sensitivity in prostate cancer.

Cheng B, Lai Y, Huang H, Peng S, Tang C, Chen J, Luo T, Wu J, He H, Wang Q, Huang H. Cheng B, et al. Among authors: he h. Environ Toxicol. 2024 Feb;39(2):927-941. doi: 10.1002/tox.23997. Epub 2023 Nov 16. Environ Toxicol. 2024. PMID: 37972062

4

Water and chloride as allosteric inhibitors in WNK kinase osmosensing.

Teixeira LR, Akella R, Humphreys JM, He H, Goldsmith EJ. Teixeira LR, et al. Among authors: he h. bioRxiv [Preprint]. 2023 Aug 31:2023.08.29.555411. doi: 10.1101/2023.08.29.555411. bioRxiv. 2023. PMID: 37693587 Free PMC article. Preprint.

5

Hydrostatic Pressure Sensing by WNK kinases.

Humphreys JM, Teixeira LR, Akella R, He H, Kannangara AR, Sekulski K, Pleinis J, Liwocha J, Jiou J, Servage KA, Orth K, Joachimiak L, Rizo J, Cobb MH, Brautigam CA, Rodan AR, Goldsmith EJ. Humphreys JM, et al. Among authors: he h. Mol Biol Cell. 2023 Oct 1;34(11):ar109. doi: 10.1091/mbc.E23-03-0113. Epub 2023 Aug 16. Mol Biol Cell. 2023. PMID: 37585288 Free PMC article.

6

TSPAN18 facilitates bone metastasis of prostate cancer by protecting STIM1 from TRIM32-mediated ubiquitination.

Zhou Q, Chen X, Yao K, Zhang Y, He H, Huang H, Chen H, Peng S, Huang M, Cheng L, Zhang Q, Xie R, Li K, Lin T, Huang H. Zhou Q, et al. Among authors: he h. J Exp Clin Cancer Res. 2023 Aug 5;42(1):195. doi: 10.1186/s13046-023-02764-4. J Exp Clin Cancer Res. 2023. PMID: 37542345 Free PMC article.

7

Aberrant JAK-STAT signaling-mediated chromatin remodeling impairs the sensitivity of NK/T-cell lymphoma to chidamide.

Chen J, Zuo Z, Gao Y, Yao X, Guan P, Wang Y, Li Z, Liu Z, Hong JH, Deng P, Chan JY, Cheah DMZ, Lim J, Chai KXY, Chia BKH, Pang JWL, Koh J, Huang D, He H, Sun Y, Liu L, Liu S, Huang Y, Wang X, You H, Saraf SA, Grigoropoulos NF, Li X, Bei J, Kang T, Lim ST, Teh BT, Huang H, Ong CK, Tan J. Chen J, et al. Among authors: he h. Clin Epigenetics. 2023 Feb 6;15(1):19. doi: 10.1186/s13148-023-01436-6. Clin Epigenetics. 2023. PMID: 36740715 Free PMC article. Clinical Trial.

8

Identification of a Class of WNK Isoform-Specific Inhibitors Through High-Throughput Screening.

Chlebowicz J, Akella R, Humphreys JM, He H, Kannangara AR, Wei S, Posner B, Goldsmith EJ. Chlebowicz J, et al. Among authors: he h. Drug Des Devel Ther. 2023 Jan 20;17:93-105. doi: 10.2147/DDDT.S389461. eCollection 2023. Drug Des Devel Ther. 2023. PMID: 36712947 Free PMC article.

9

Synthesis and Structural Characterization of Novel Trihalo-sulfone Inhibitors of WNK1.

Rodriguez M, Kannangara A, Chlebowicz J, Akella R, He H, Tambar UK, Goldsmith EJ. Rodriguez M, et al. Among authors: he h. ACS Med Chem Lett. 2022 Sep 23;13(10):1678-1684. doi: 10.1021/acsmedchemlett.2c00216. eCollection 2022 Oct 13. ACS Med Chem Lett. 2022. PMID: 36262391 Free PMC article.

10

The emerging role of anti-PD-1 antibody-based regimens in the treatment of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis.

He Y, Gao Y, Ping L, He H, Huang C, Bai B, Wang X, Li Z, Cai Q, Huang Y, Pan X, Zeng W, Liu Y, Huang H. He Y, et al. Among authors: he h. J Cancer Res Clin Oncol. 2023 May;149(5):2017-2027. doi: 10.1007/s00432-022-04147-2. Epub 2022 Jul 9. J Cancer Res Clin Oncol. 2023. PMID: 35809114

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

53 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year